• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2 型糖尿病、非酒精性脂肪性肝病和代谢反应:恶性循环及其与炎症的相互作用。

Type 2 Diabetes Mellitus, Non-Alcoholic Fatty Liver Disease, and Metabolic Repercussions: The Vicious Cycle and Its Interplay with Inflammation.

机构信息

Students' Research Club, Department of Clinical Pharmacology, Medical University of Lodz, 90-153 Lodz, Poland.

Department of Clinical Electrocardiology, Medical University of Lodz, 92-213 Lodz, Poland.

出版信息

Int J Mol Sci. 2023 Jun 2;24(11):9677. doi: 10.3390/ijms24119677.

DOI:10.3390/ijms24119677
PMID:37298632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10254034/
Abstract

The prevalence of metabolic-related disorders, such as non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (DM2), has been increasing. Therefore, developing improved methods for the prevention, treatment, and detection of these two conditions is also necessary. In this study, our primary focus was on examining the role of chronic inflammation as a potential link in the pathogenesis of these diseases and their interconnections. A comprehensive search of the PubMed database using keywords such as "non-alcoholic fatty liver disease", "type 2 diabetes mellitus", "chronic inflammation", "pathogenesis", and "progression" yielded 177 relevant papers for our analysis. The findings of our study revealed intricate relationships between the pathogenesis of NAFLD and DM2, emphasizing the crucial role of inflammatory processes. These connections involve various molecular functions, including altered signaling pathways, patterns of gene methylation, the expression of related peptides, and up- and downregulation of several genes. Our study is a foundational platform for future research into the intricate relationship between NAFLD and DM2, allowing for a better understanding of the underlying mechanisms and the potential for introducing new treatment standards.

摘要

代谢相关疾病的患病率不断上升,如非酒精性脂肪性肝病(NAFLD)和 2 型糖尿病(DM2)。因此,开发预防、治疗和检测这两种疾病的改良方法也是必要的。在这项研究中,我们主要关注慢性炎症作为这些疾病发病机制及其相互关联的潜在联系的作用。使用“非酒精性脂肪性肝病”、“2 型糖尿病”、“慢性炎症”、“发病机制”和“进展”等关键词,对 PubMed 数据库进行全面检索,共获得 177 篇相关论文进行分析。我们的研究结果揭示了 NAFLD 和 DM2 发病机制之间的复杂关系,强调了炎症过程的关键作用。这些联系涉及各种分子功能,包括信号通路改变、基因甲基化模式、相关肽的表达以及多个基因的上调和下调。我们的研究为 NAFLD 和 DM2 之间复杂关系的未来研究提供了一个基础平台,有助于更好地理解潜在机制,并有可能引入新的治疗标准。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae1f/10254034/84891df9ab8d/ijms-24-09677-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae1f/10254034/6ef013d24623/ijms-24-09677-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae1f/10254034/d6cb2290d778/ijms-24-09677-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae1f/10254034/84891df9ab8d/ijms-24-09677-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae1f/10254034/6ef013d24623/ijms-24-09677-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae1f/10254034/d6cb2290d778/ijms-24-09677-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae1f/10254034/84891df9ab8d/ijms-24-09677-g003.jpg

相似文献

1
Type 2 Diabetes Mellitus, Non-Alcoholic Fatty Liver Disease, and Metabolic Repercussions: The Vicious Cycle and Its Interplay with Inflammation.2 型糖尿病、非酒精性脂肪性肝病和代谢反应:恶性循环及其与炎症的相互作用。
Int J Mol Sci. 2023 Jun 2;24(11):9677. doi: 10.3390/ijms24119677.
2
Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment.非酒精性脂肪性肝病与糖尿病:从生理病理相互作用到诊断与治疗
World J Gastroenterol. 2014 Jul 14;20(26):8377-92. doi: 10.3748/wjg.v20.i26.8377.
3
[Non-alcoholic fatty liver disease and type 2 diabetes mellitus. I. Pathogenesis].[非酒精性脂肪性肝病与2型糖尿病。I.发病机制]
Orv Hetil. 2022 May 22;163(21):815-825. doi: 10.1556/650.2022.32479.
4
The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD).2 型糖尿病(T2DM)、胰岛素抵抗(IR)与非酒精性脂肪性肝病(NAFLD)之间错综复杂的关系。
J Diabetes Res. 2020 Jul 31;2020:3920196. doi: 10.1155/2020/3920196. eCollection 2020.
5
Relationship between Oxidative Stress, Inflammation and Dyslipidemia with Fatty Liver Index in Patients with Type 2 Diabetes Mellitus.2型糖尿病患者氧化应激、炎症、血脂异常与脂肪肝指数的关系
Exp Clin Endocrinol Diabetes. 2018 Jun;126(6):371-378. doi: 10.1055/s-0043-118667. Epub 2017 Sep 11.
6
Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.非酒精性脂肪性肝病、代谢风险因素与肝细胞癌:一个悬而未决的问题。
World J Gastroenterol. 2015 Apr 14;21(14):4103-10. doi: 10.3748/wjg.v21.i14.4103.
7
[The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities].[关于非酒精性脂肪性肝病成年患者及主要合并症管理的全国共识声明]
Ter Arkh. 2022 Feb 15;94(2):216-253. doi: 10.26442/00403660.2022.02.201363.
8
[Non-alcoholic steatohepatitis (NASH) : a model of metabolic inflammation («metaflammation»)].非酒精性脂肪性肝炎(NASH):一种代谢性炎症(“元炎症”)模型
Rev Med Liege. 2022 May;77(5-6):316-322.
9
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?非酒精性脂肪性肝病与2型糖尿病:我们这个时代的肝脏疾病?
World J Gastroenterol. 2014 Jul 21;20(27):9072-89. doi: 10.3748/wjg.v20.i27.9072.
10
A global view of the interplay between non-alcoholic fatty liver disease and diabetes.非酒精性脂肪性肝病与糖尿病之间相互作用的全球观。
Lancet Diabetes Endocrinol. 2022 Apr;10(4):284-296. doi: 10.1016/S2213-8587(22)00003-1. Epub 2022 Feb 17.

引用本文的文献

1
Resveratrol attenuates hepatic oxidative stress and preserves gut mucosal integrity in high-fat diet-fed rats by modulating antioxidant and anti-inflammatory pathways.白藜芦醇通过调节抗氧化和抗炎途径减轻高脂饮食喂养大鼠的肝脏氧化应激并维持肠道黏膜完整性。
Sci Rep. 2025 Jul 11;15(1):25162. doi: 10.1038/s41598-025-08450-z.
2
Aggregate index of systemic inflammation tied to increased fatty liver disease risk: insights from NHANES data.与脂肪肝疾病风险增加相关的全身炎症综合指数:来自美国国家健康与营养检查调查(NHANES)数据的见解
BMC Gastroenterol. 2025 May 23;25(1):399. doi: 10.1186/s12876-025-03998-6.
3
Efficacy and safety of GLP-1 receptor agonists on weight management and metabolic parameters in PCOS women: a meta-analysis of randomized controlled trials.

本文引用的文献

1
Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus-The Chicken or the Egg Dilemma.非酒精性脂肪性肝病还是2型糖尿病——先有鸡还是先有蛋的困境。
Biomedicines. 2023 Apr 4;11(4):1097. doi: 10.3390/biomedicines11041097.
2
2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023.2. 糖尿病的分类和诊断:2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S19-S40. doi: 10.2337/dc23-S002.
3
MAFLD: How is it different from NAFLD?MAFLD:与非酒精性脂肪性肝病(NAFLD)有何不同?
胰高血糖素样肽-1受体激动剂对多囊卵巢综合征女性体重管理和代谢参数的疗效及安全性:一项随机对照试验的荟萃分析
Sci Rep. 2025 May 13;15(1):16512. doi: 10.1038/s41598-025-99622-4.
4
Age-specific associations of RBC folate and several serum folate forms with obesity risk: NHANES 2011-2018.2011 - 2018年美国国家健康与营养检查调查(NHANES)中红细胞叶酸及多种血清叶酸形式与肥胖风险的年龄特异性关联
Front Nutr. 2025 Apr 10;12:1547844. doi: 10.3389/fnut.2025.1547844. eCollection 2025.
5
Nuclear factor erythroid 2-related factor 2 ameliorates disordered glucose and lipid metabolism in liver: Involvement of gasdermin D in regulating pyroptosis.核因子红细胞2相关因子2改善肝脏中紊乱的糖脂代谢:gasdermin D参与调节细胞焦亡。
Clin Transl Med. 2025 Mar;15(3):e70233. doi: 10.1002/ctm2.70233.
6
Development and validation of a prognostic model for critically ill type 2 diabetes patients in ICU based on composite inflammatory indicators.基于复合炎症指标的ICU中重症2型糖尿病患者预后模型的建立与验证
Sci Rep. 2025 Jan 29;15(1):3627. doi: 10.1038/s41598-025-87731-z.
7
Nursing interventions guided by the theory of stress and adaptation improve the self-management ability of T2DM patients.以压力与适应理论为指导的护理干预可提高2型糖尿病患者的自我管理能力。
Am J Transl Res. 2024 Dec 15;16(12):7734-7741. doi: 10.62347/NBKN4311. eCollection 2024.
8
Therapeutic Potential of Dimethyl Fumarate for the Treatment of High-Fat/High-Sucrose Diet-Induced Obesity.富马酸二甲酯治疗高脂/高糖饮食诱导的肥胖症的治疗潜力
Antioxidants (Basel). 2024 Dec 8;13(12):1496. doi: 10.3390/antiox13121496.
9
Association of liver fibrosis scores with all-cause and cardiovascular mortality in patients with heart failure.心力衰竭患者肝纤维化评分与全因死亡率和心血管死亡率的关联
Clin Transl Sci. 2024 Dec;17(12):e70104. doi: 10.1111/cts.70104.
10
The Involvement of Resolvins in Pathological Mechanisms of Periodontal Disease Associated with Type 2 Diabetes: A Narrative Review.消退素在2型糖尿病相关牙周病病理机制中的作用:一项叙述性综述
Int J Mol Sci. 2024 Nov 28;25(23):12784. doi: 10.3390/ijms252312784.
Clin Mol Hepatol. 2023 Feb;29(Suppl):S17-S31. doi: 10.3350/cmh.2022.0367. Epub 2022 Nov 29.
4
Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism.双硫仑通过调节肠道微生物群和胆汁酸代谢改善非酒精性脂肪性肝炎。
Nat Commun. 2022 Nov 11;13(1):6862. doi: 10.1038/s41467-022-34671-1.
5
Effectiveness and safety of human umbilical cord-mesenchymal stem cells for treating type 2 diabetes mellitus.人脐带间充质干细胞治疗2型糖尿病的有效性和安全性
World J Diabetes. 2022 Oct 15;13(10):877-887. doi: 10.4239/wjd.v13.i10.877.
6
Evogliptin Directly Inhibits Inflammatory and Fibrotic Signaling in Isolated Liver Cells.依格列净直接抑制分离肝细胞中的炎症和纤维化信号通路。
Int J Mol Sci. 2022 Oct 1;23(19):11636. doi: 10.3390/ijms231911636.
7
Progress in Nonalcoholic Fatty Liver Disease: SIRT Family Regulates Mitochondrial Biogenesis.非酒精性脂肪性肝病的研究进展:SIRT 家族调节线粒体生物发生。
Biomolecules. 2022 Aug 5;12(8):1079. doi: 10.3390/biom12081079.
8
Macrophages, Low-Grade Inflammation, Insulin Resistance and Hyperinsulinemia: A Mutual Ambiguous Relationship in the Development of Metabolic Diseases.巨噬细胞、低度炎症、胰岛素抵抗和高胰岛素血症:代谢性疾病发展中的相互模糊关系
J Clin Med. 2022 Jul 27;11(15):4358. doi: 10.3390/jcm11154358.
9
Comparison of delta-tocotrienol and alpha-tocopherol effects on hepatic steatosis and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: A randomized double-blind active-controlled trial.比较生育三烯酚和α-生育酚对非酒精性脂肪性肝病患者肝脂肪变性和炎症生物标志物的影响:一项随机、双盲、活性对照试验。
Complement Ther Med. 2022 Nov;70:102866. doi: 10.1016/j.ctim.2022.102866. Epub 2022 Aug 3.
10
Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial.粪便微生物移植治疗非酒精性脂肪性肝病的随机临床试验。
Front Cell Infect Microbiol. 2022 Jul 4;12:759306. doi: 10.3389/fcimb.2022.759306. eCollection 2022.